Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?
Portfolio Pulse from
Amgen's stock experienced a significant drop of over 12% during a trading session due to a negative market reaction to its latest clinical data update. However, the stock partially recovered, closing 4.7% down for the day.
November 30, 2024 | 11:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Amgen's stock dropped significantly due to a negative market reaction to its clinical data update, but partially recovered by the end of the trading session.
The significant intraday drop in Amgen's stock price indicates a strong negative market reaction to the clinical data update. Although the stock partially recovered, the initial reaction suggests potential short-term volatility and investor concern.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100